USPTO serial 79043515
MEDIGENE
Reviewed by CopyMark Law Group
Reg. 3591359Status 709
- Filing date
- Status date
- Registration date
- Mar 17, 2009
- Examiner
- FRENCH, CURTIS W
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDIGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Adrienne L. White
Adrienne L. White WRB-IP LLPP.O. Box 476Wadsworth, OH 44282UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for humans and animals, except venous-therapeutics, namely, medicines for treating [ cardiovascular and vascular diseases, ] dermatological disorders and diseases, [ precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases, vaccines for treating cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; serums, namely, immune serums for passive vaccination for treating infectious diseases, diagnostic test kits comprising antibodies, antibody fragments, serums, soluble monoclonal T-cell receptors, peptides, peptide-analogues, enzymes, liposomes, dyes, radioactively labeled substances, for the purpose of testing, diagnosing and monitoring cardiovascular and vascular diseases, dermatological disorders and diseases, precancerous diseases, benign and malignant tumors, infectious diseases, allergic and asthmatic diseases, neurodegenerative diseases, autoimmune diseases, diseases of the respiratory tract, gastrointestinal diseases, blood disorders, aging-associated diseases, genetic disorders, metabolic disorders, musculoskeletal disorders and eye diseases; proteins, proteinconjugates, peptides, enzymes and enzyme-preparations, antibodies, T-cell-proteins, attenuated viruses, virus-like particles, liposomes, ] herbal extracts, components of low molecular weight, all for use as medicines [, vaccines and parts of medical diagnostic test kits for treating, testing, diagnosing and monitoring all diseases mentioned above ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 9, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 1, 2021 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 1, 2021 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Aug 23, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 17, 2018 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 11, 2017 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 23, 2015 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 23, 2015 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 23, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 17, 2015 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jan 12, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 24, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 1, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 17, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 27, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 17, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 12, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 12, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 30, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 10, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 25, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 25, 2008 | ALIE | ASSIGNED TO LIE | — |
| Nov 20, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 18, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 17, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 17, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 26, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 25, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 25, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 11, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |